A detailed history of Bank Of Montreal transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Bank Of Montreal holds 12,556 shares of CORT stock, worth $722,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,556
Previous 12,156 3.29%
Holding current value
$722,472
Previous $394,000 47.21%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$29.51 - $46.26 $11,804 - $18,504
400 Added 3.29%
12,556 $580,000
Q2 2024

Aug 14, 2024

BUY
$22.21 - $34.48 $12,881 - $19,998
580 Added 5.01%
12,156 $394,000
Q1 2024

May 13, 2024

SELL
$21.1 - $27.46 $1,688 - $2,196
-80 Reduced 0.69%
11,576 $291,000
Q4 2023

Feb 08, 2024

BUY
$24.82 - $32.88 $19,185 - $25,416
773 Added 7.1%
11,656 $378,000
Q3 2023

Nov 01, 2023

SELL
$21.97 - $33.8 $466,686 - $717,979
-21,242 Reduced 66.12%
10,883 $296,000
Q2 2023

Aug 02, 2023

SELL
$21.44 - $25.15 $3.21 Million - $3.77 Million
-149,742 Reduced 82.34%
32,125 $714,000
Q1 2023

Jun 13, 2024

BUY
$19.2 - $24.47 $60,691 - $77,349
3,161 Added 27.31%
14,737 $319,000
Q4 2022

Feb 01, 2023

SELL
$19.95 - $29.96 $581,722 - $873,603
-29,159 Reduced 13.82%
181,867 $3.69 Million
Q3 2022

Nov 10, 2022

BUY
$24.7 - $29.12 $88,994 - $104,919
3,603 Added 1.74%
211,026 $5.85 Million
Q2 2022

Aug 11, 2022

BUY
$17.33 - $25.3 $3.14 Million - $4.58 Million
180,918 Added 682.58%
207,423 $5.26 Million
Q1 2022

May 12, 2022

SELL
$16.53 - $25.21 $23,108 - $35,243
-1,398 Reduced 5.01%
26,505 $643,000
Q4 2021

Feb 11, 2022

SELL
$17.1 - $23.34 $138,817 - $189,474
-8,118 Reduced 22.54%
27,903 $544,000
Q3 2021

Nov 12, 2021

SELL
$19.68 - $22.53 $37,884 - $43,370
-1,925 Reduced 5.07%
36,021 $731,000
Q2 2021

Aug 12, 2021

BUY
$19.97 - $24.43 $757,781 - $927,020
37,946 New
37,946 $846,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.